Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma
Owen, C, Berinstein, N L, Christofides, A, Sehn, L H
Published in Current oncology (Toronto) (01.04.2019)
Published in Current oncology (Toronto) (01.04.2019)
Get full text
Journal Article
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Morschhauser, Franck, Fowler, Nathan H, Feugier, Pierre, Bouabdallah, Reda, Tilly, Hervé, Palomba, M. Lia, Fruchart, Christophe, Libby, Edward N, Casasnovas, Rene-Olivier, Flinn, Ian W, Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L, Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Daguindau, Nicolas, Le Gouill, Steven, Pica, Gian M, Martin Garcia-Sancho, Alejandro, López-Guillermo, Armando, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Zachée, Pierre, Sehn, Laurie H, Tobinai, Kensei, Cartron, Guillaume, Liu, David, Wang, Jianming, Xerri, Luc, Salles, Gilles A
Published in The New England journal of medicine (06.09.2018)
Published in The New England journal of medicine (06.09.2018)
Get full text
Journal Article
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J.F., Kelly, K., Gribben, J., Pfreunschuh, M., Morschhauser, F., Schoder, H., Zelenetz, A.D., Rademaker, J., Advani, R., Valente, N., Fortpied, C., Witzig, T.E., Sehn, L.H., Engert, A., Fisher, R.I., Zinzani, P.-L., Federico, M., Hutchings, M., Bollard, C., Trneny, M., Elsayed, Y.A., Tobinai, K., Abramson, J.S., Fowler, N., Goy, A., Smith, M., Ansell, S., Kuruvilla, J., Dreyling, M., Thieblemont, C., Little, R.F., Aurer, I., Van Oers, M.H.J., Takeshita, K., Gopal, A., Rule, S., de Vos, S., Kloos, I., Kaminski, M.S., Meignan, M., Schwartz, L.H., Leonard, J.P., Schuster, S.J., Seshan, V.E.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
Long-Term Outcomes for Patients with Limited Stage Follicular Lymphoma: An Update of a Population-based Study
Lo, A.C., Campbell, B.A., Pickles, T., Aquino-Parsons, C., Sehn, L.H., Connors, J.M., Savage, K.J.
Published in International journal of radiation oncology, biology, physics (01.09.2019)
Published in International journal of radiation oncology, biology, physics (01.09.2019)
Get full text
Journal Article
Observation as the initial management strategy in patients with mantle cell lymphoma
Abrisqueta, P., Scott, D.W., Slack, G.W., Steidl, C., Mottok, A., Gascoyne, R.D., Connors, J.M., Sehn, L.H., Savage, K.J., Gerrie, A.S., Villa, D.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
The Impact of Surveillance Imaging After Curative Intent Radiotherapy for Limited Stage Follicular Lymphoma
Urban, R., Chow, R., Pickles, T., Chan, M., Livergant, J., Gerrie, A., Freeman, C., Sehn, L.H., Scott, D., Villa, D., Savage, K.J., Slack, G., Lo, A.C.
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Get full text
Journal Article
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
Villa, D., Connors, J.M., Shenkier, T.N., Gascoyne, R.D., Sehn, L.H., Savage, K.J.
Published in Annals of oncology (01.05.2010)
Published in Annals of oncology (01.05.2010)
Get full text
Journal Article
Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic
Sehn, L H, Kuruvilla, P, Christofides, A, Stakiw, J
Published in Current oncology (Toronto) (01.06.2020)
Published in Current oncology (Toronto) (01.06.2020)
Get full text
Journal Article
The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study
Alzahrani, M., El-Galaly, T.C., Hutchings, M., Hansen, J.W., Loft, A., Johnsen, H.E., Iyer, V., Wilson, D., Sehn, L.H., Savage, K.J., Connors, J.M., Gascoyne, R.D., Johansen, P., Clasen-Linde, E., Brown, P., Villa, D.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency
Ramadan, K.M., Shenkier, T., Sehn, L.H., Gascoyne, R.D., Connors, J.M.
Published in Annals of oncology (01.01.2007)
Published in Annals of oncology (01.01.2007)
Get full text
Journal Article
Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma
Skrabek, P, Assouline, S, Christofides, A, MacDonald, D, Prica, A, Sangha, R, Matthews, B A, Sehn, L H
Published in Current oncology (Toronto) (01.08.2019)
Published in Current oncology (Toronto) (01.08.2019)
Get full text
Journal Article
Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia
Banerji, V, Aw, A, Robinson, S, Doucette, S, Christofides, A, Sehn, L H
Published in Current oncology (Toronto) (01.12.2020)
Published in Current oncology (Toronto) (01.12.2020)
Get full text
Journal Article
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Gerrie, A.S., Power, M.M., Shepherd, J.D., Savage, K.J., Sehn, L.H., Connors, J.M.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL
Trněný, M., Canales Ruiz, I., Martelli, M., Sehn, L.H., Vitolo, U., Brown, H., Nielsen, T., Sellam, G., Kostakoglu, L.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
ESTIMATION OF LONG‐TERM SURVIVAL WITH POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB FOR PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Sehn, L.H., Flowers, C., McMillan, A., Morschhauser, F., Salles, G., Felizzi, F., Launonen, A., Qayum, N., Thuresson, P.O.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
Emerging therapies for the treatment of relapsed or refractory follicular lymphoma
MacDonald, D, Prica, A, Assouline, S, Christofides, A, Lawrence, T, Sehn, L H
Published in Current oncology (Toronto) (01.12.2016)
Published in Current oncology (Toronto) (01.12.2016)
Get full text
Journal Article
POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB OR OBINUTUZUMAB IN RELAPSED/REFRACTORY FL OR DLBCL: UPDATED RESULTS OF A PHASE 1B/2 STUDY
Matasar, M., Herrera, A.F., Kamdar, M., Mehta, A., Assouline, S., Fleury, I., Kim, T.M., Kim, W.S., Bosch, F., Radford, J., Flowers, C.R., Bu, L., Hong, W., Sehn, L.H.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
RADIOMICS INCREASE THE PROGNOSTIC VALUE OF CLINICAL AND PET RISK FACTORS IN DLBCL: RESULTS FROM THE PHASE 3 GOYA STUDY
Chauvie, S., Dalmasso, F., Pierce, L., Vitolo, U., Martelli, M., Sehn, L.H., Trněný, M., Nielsen, T., Sahin, D., Lee, C., Mattiello, F., Berchialla, P., Kinahan, P.E., Kostakoglu, L.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
POLARIX: A PHASE 3 STUDY OF POLATUZUMAB VEDOTIN (POLA) PLUS R‐CHP VERSUS R‐CHOP IN PATIENTS (PTS) WITH UNTREATED DLBCL
Tilly, H., Flowers, C., Friedberg, J.W., Herbaux, C., Morschhauser, F., Sehn, L.H., Sharman, J., Trněný, M., Lee, C., Salles, G.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article